<DOC>
	<DOCNO>NCT01106807</DOCNO>
	<brief_summary>The purpose study evaluate efficacy CD07223 1.5 % Gel 0.5 % gel reduce inflammatory , non-inflammatory , total acne lesion count 6 week twice daily application . The study also evaluate safety study product use tolerance adverse event data .</brief_summary>
	<brief_title>Exploratory Study Evaluate Efficacy Safety CD07223 Gel Subjects With Acne</brief_title>
	<detailed_description />
	<mesh_term>Adapalene , Benzoyl Peroxide Drug Combination</mesh_term>
	<mesh_term>Adapalene</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>subject clinical diagnosis acne vulgaris facial involvement subject least 15 inflammatory lesion 25 noninflammatory lesion ( exclude nose ) 2 nodule face subject severe acne form secondary acne form number inflammatory noninflammatory lesion one halfface great twice number halfface subject know allergy sensitivity component study product subject willing respect washout period topical and/or systemic treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>